- Home
- STRO vs FRST Comparison
STRO vs FRST Comparison
Compare STRO & FRST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- FRST
- Stock Information
- Founded
- STRO 2003
- FRST 2004
- Country
- STRO United States
- FRST United States
- Employees
- STRO N/A
- FRST N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- FRST Major Banks
- Sector
- STRO Health Care
- FRST Finance
- Exchange
- STRO Nasdaq
- FRST Nasdaq
- Market Cap
- STRO 77.7M
- FRST 220.5M
- IPO Year
- STRO 2018
- FRST 2006
- Fundamental
- Price
- STRO $0.75
- FRST $10.81
- Analyst Decision
- STRO Hold
- FRST Buy
- Analyst Count
- STRO 7
- FRST 1
- Target Price
- STRO $3.97
- FRST $420.00
- AVG Volume (30 Days)
- STRO 1.4M
- FRST 79.6K
- Earning Date
- STRO 08-12-2025
- FRST 07-24-2025
- Dividend Yield
- STRO N/A
- FRST 3.67%
- EPS Growth
- STRO N/A
- FRST N/A
- EPS
- STRO N/A
- FRST 0.16
- Revenue
- STRO $66,434,000.00
- FRST $125,133,000.00
- Revenue This Year
- STRO N/A
- FRST $21.33
- Revenue Next Year
- STRO N/A
- FRST $12.77
- P/E Ratio
- STRO N/A
- FRST $67.95
- Revenue Growth
- STRO N/A
- FRST 22.34
- 52 Week Low
- STRO $0.52
- FRST $7.59
- 52 Week High
- STRO $5.17
- FRST $13.52
- Technical
- Relative Strength Index (RSI)
- STRO 38.33
- FRST 71.55
- Support Level
- STRO $0.76
- FRST $10.40
- Resistance Level
- STRO $0.87
- FRST $10.75
- Average True Range (ATR)
- STRO 0.07
- FRST 0.22
- MACD
- STRO -0.01
- FRST 0.08
- Stochastic Oscillator
- STRO 0.00
- FRST 94.78
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About FRST Primis Financial Corp.
Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses. Primis Bank offers a wide range of commercial banking services, It focuses on making loans secured mainly by commercial real estate and other types of secured and unsecured commercial loans to small and medium-sized businesses in several industries, as well as loans to individuals for a variety of purposes. Primis Bank offers a broad range of deposit products, including checking (NOW), savings, money market accounts, and certificates of deposit.